The document discusses poliomyelitis (polio), including:
- Polio is an acute viral infection caused by poliovirus that can cause paralysis. It is transmitted through the fecal-oral route or droplets.
- There are three types of poliovirus. Infection results in subclinical, abortive, non-paralytic, or paralytic cases. Paralysis occurs when the virus infects motor neurons in the spinal cord.
- Pakistan saw over 1,000 polio cases in 1997 but improved vaccination programs have reduced this to single digits by 2022. Oral and inactivated polio vaccines are used to prevent transmission and eradicate the disease.
THESE SLIDES ARE PREPAREED TO UNDERSTAND about communicable diseases IN EASY WAY Important links- NOTES- https://mynursingstudents.blogspot.com/ youtube channel https://www.youtube.com/c/MYSTUDENTSU... CHANEL PLAYLIST- ANATOMY AND PHYSIOLOGY-https://www.youtube.com/playlist?list=PL93S13oM2gAPM3VTGVUXIeswKJ3XGaD2p COMMUNITY HEALTH NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gAPyslPNdIJoVjiXEDTVEDzs CHILD HEALTH NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gANcslmv0DXg6BWmWN359Gvg FIRST AID- https://www.youtube.com/playlist?list=PL93S13oM2gAMvGqeqH2ZTklzFAZhOrvgP HCM- https://www.youtube.com/playlist?list=PL93S13oM2gAM7mZ1vZhQBHWbdLnLb-cH9 FUNDAMENTALS OF NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gAPFxu78NDLpGPaxEmK1fTao COMMUNICABLE DISEASES- https://www.youtube.com/playlist?list=PL93S13oM2gAOWo4IwNjLU_LCuhRN0ZLeb ENVIRONMENTAL HEALTH- https://www.youtube.com/playlist?list=PL93S13oM2gAPkI6LvfS8Zu1nm6mZi9FK6 MSN- https://www.youtube.com/playlist?list=PL93S13oM2gAOdyoHnDLAoR_o8M6ccqYBm HINDI ONLY- https://www.youtube.com/playlist?list=PL93S13oM2gAN4L-FJ3s_IEXgZCijGUA1A ENGLISH ONLY- https://www.youtube.com/playlist?list=PL93S13oM2gAMYv2a1hFcq4W1nBjTnRkHP facebook profile- https://www.facebook.com/suresh.kr.lrhs/ FACEBOOK PAGE- https://www.facebook.com/My-Student-S... facebook group NURSING NOTES- https://www.facebook.com/groups/24139... FOR MAKING EASY NOTES YOU CAN ALSO VISIT MY BLOG – BLOGGER- https://mynursingstudents.blogspot.com/ Instagram- https://www.instagram.com/mystudentsu... Twitter- https://twitter.com/student_system?s=08 #PEM, #polio,#communicablediseases,#ASSESSMENT, #APPEARENCE,#PULSE,#GRIMACE,#REFLEX,#RESPIRATION,#RESUSCITATION,#NEWBORN,#BABY,#VIRGINIA, #CHILD, #OXYGEN,#CYANOSIS,#OPTICNERVE, #SARACHNA,#MYSTUDENTSUPPORTSYSTEM, #rashes,#nursingclasses, #communityhealthnursing,#ANM, #GNM, #BSCNURING,#NURSINGSTUDENTS, #WHO,#NURSINGINSTITUTION,#COLLEGEOFNURSING,#nursingofficer,#COMMUNITYHEALTHOFFICE,#HEALTHPROBLEMS
polio virus lecture for MBBS
The picornaviruses are small (22 to 30 nm) nonenveloped, single-stranded RNA viruses with cubic symmetry. The virus capsid is composed of 60 protein subunits, each consisting of four poly-peptides VP1–VP4. Because they contain no essential lipids, they are ether resistant. They replicate in the cytoplasm.
Polio or poliomyelitis is first known to have occurred nearly 6,000 years ago, as evidenced by the withered and deformed limbs of certain Egyptian mummies.
Polio was epidemic in the United States and the world in the 20th century, especially in the 1940s and 1950s.
Poliomyelitis is a highly infectious viral disease, which mostly affects young children; the virus is transmitted by person-to-person spread mainly through the fecal-oral route, or, less frequently, by a common vehicle (e.g. contaminated food or water) and multiplies in the intestine, from where it can invade the nervous system and can cause paralysis.
Initial symptoms of polio include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs.
Etiology
Polioviruses are enteroviruses within the Picornaviridae family.
Direct contact. Poliovirus can be transmitted through direct contact with someone infected with the virus.
Ingestion. Less commonly, it can be transmitted through contaminated food and water.
Clinical Manifestations
Most patients infected with poliovirus develop inapparent infections and are frequently asymptomatic.
Nonspecific symptoms. Fever, headache, nausea, vomiting, abdominal pain, and oropharyngeal hyperemia are observed in mild cases and usually resolve within a few days.
Nonparalytic poliomyelitis. Nonparalytic poliomyelitis is characterized by the symptoms described above in addition to the following: nuchal rigidity, more severe headache, back, and lower extremity pain, and meningitis with lymphocytic pleocytosis (usually).
Assessment and Diagnostic Findings
To confirm the diagnosis, a sample of throat secretions, stool or a colorless fluid that surrounds your brain and spinal cord (cerebrospinal fluid) is checked for poliovirus.
Viral cultures. Obtain specimens from the cerebrospinal fluid (CSF), stool, and throat for viral cultures in patients with suspected poliomyelitis infection.
Serum antibody. Obtain acute and convalescent serum for antibody concentrations against the 3 polioviruses.
IG titer. A 4-fold increase in the immunoglobulin G (IgG) antibody titers or a positive anti-immunoglobulin M (IgM) titer during the acute stage is diagnostic.
Medical Management
The treatment of poliomyelitis is mainly supportive.
Physical therapy. Physical therapy is indicated in cases of paralytic disease; in paralytic disease, it provide frequent mobilization to avoid the development of chronic decubitus ulcerations; active and passive motion exercises are indicated during the convalescent stage.
Total hip arthroplasty. Total hip arthroplasty is a surgical therapeutic option for patients with paralytic sequelae of poliomyelitis who develop hip dysplasia and degenerative disease.
Diet. Because patients with poliomyelitis are prone to develop constipation, a diet rich in fiber is usually indicated.
Pharmacologic Management
No antiviral agents are effective against poliovirus.
Picornaviruses presentation for medical student created by: Farhang Shapouran
References : Moray medical microbiology, Jawetz medical microbiology, ICTV
Poliovirus is a picornaviridae. it has 3 wildtypes, Wildtype 2 has been eradicated from the world. All countries have been declared polio free except Pakistan, Afghanistan and Nigeria. Global Polio Eradication Initiative has been discussed.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
THESE SLIDES ARE PREPAREED TO UNDERSTAND about communicable diseases IN EASY WAY Important links- NOTES- https://mynursingstudents.blogspot.com/ youtube channel https://www.youtube.com/c/MYSTUDENTSU... CHANEL PLAYLIST- ANATOMY AND PHYSIOLOGY-https://www.youtube.com/playlist?list=PL93S13oM2gAPM3VTGVUXIeswKJ3XGaD2p COMMUNITY HEALTH NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gAPyslPNdIJoVjiXEDTVEDzs CHILD HEALTH NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gANcslmv0DXg6BWmWN359Gvg FIRST AID- https://www.youtube.com/playlist?list=PL93S13oM2gAMvGqeqH2ZTklzFAZhOrvgP HCM- https://www.youtube.com/playlist?list=PL93S13oM2gAM7mZ1vZhQBHWbdLnLb-cH9 FUNDAMENTALS OF NURSING- https://www.youtube.com/playlist?list=PL93S13oM2gAPFxu78NDLpGPaxEmK1fTao COMMUNICABLE DISEASES- https://www.youtube.com/playlist?list=PL93S13oM2gAOWo4IwNjLU_LCuhRN0ZLeb ENVIRONMENTAL HEALTH- https://www.youtube.com/playlist?list=PL93S13oM2gAPkI6LvfS8Zu1nm6mZi9FK6 MSN- https://www.youtube.com/playlist?list=PL93S13oM2gAOdyoHnDLAoR_o8M6ccqYBm HINDI ONLY- https://www.youtube.com/playlist?list=PL93S13oM2gAN4L-FJ3s_IEXgZCijGUA1A ENGLISH ONLY- https://www.youtube.com/playlist?list=PL93S13oM2gAMYv2a1hFcq4W1nBjTnRkHP facebook profile- https://www.facebook.com/suresh.kr.lrhs/ FACEBOOK PAGE- https://www.facebook.com/My-Student-S... facebook group NURSING NOTES- https://www.facebook.com/groups/24139... FOR MAKING EASY NOTES YOU CAN ALSO VISIT MY BLOG – BLOGGER- https://mynursingstudents.blogspot.com/ Instagram- https://www.instagram.com/mystudentsu... Twitter- https://twitter.com/student_system?s=08 #PEM, #polio,#communicablediseases,#ASSESSMENT, #APPEARENCE,#PULSE,#GRIMACE,#REFLEX,#RESPIRATION,#RESUSCITATION,#NEWBORN,#BABY,#VIRGINIA, #CHILD, #OXYGEN,#CYANOSIS,#OPTICNERVE, #SARACHNA,#MYSTUDENTSUPPORTSYSTEM, #rashes,#nursingclasses, #communityhealthnursing,#ANM, #GNM, #BSCNURING,#NURSINGSTUDENTS, #WHO,#NURSINGINSTITUTION,#COLLEGEOFNURSING,#nursingofficer,#COMMUNITYHEALTHOFFICE,#HEALTHPROBLEMS
polio virus lecture for MBBS
The picornaviruses are small (22 to 30 nm) nonenveloped, single-stranded RNA viruses with cubic symmetry. The virus capsid is composed of 60 protein subunits, each consisting of four poly-peptides VP1–VP4. Because they contain no essential lipids, they are ether resistant. They replicate in the cytoplasm.
Polio or poliomyelitis is first known to have occurred nearly 6,000 years ago, as evidenced by the withered and deformed limbs of certain Egyptian mummies.
Polio was epidemic in the United States and the world in the 20th century, especially in the 1940s and 1950s.
Poliomyelitis is a highly infectious viral disease, which mostly affects young children; the virus is transmitted by person-to-person spread mainly through the fecal-oral route, or, less frequently, by a common vehicle (e.g. contaminated food or water) and multiplies in the intestine, from where it can invade the nervous system and can cause paralysis.
Initial symptoms of polio include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs.
Etiology
Polioviruses are enteroviruses within the Picornaviridae family.
Direct contact. Poliovirus can be transmitted through direct contact with someone infected with the virus.
Ingestion. Less commonly, it can be transmitted through contaminated food and water.
Clinical Manifestations
Most patients infected with poliovirus develop inapparent infections and are frequently asymptomatic.
Nonspecific symptoms. Fever, headache, nausea, vomiting, abdominal pain, and oropharyngeal hyperemia are observed in mild cases and usually resolve within a few days.
Nonparalytic poliomyelitis. Nonparalytic poliomyelitis is characterized by the symptoms described above in addition to the following: nuchal rigidity, more severe headache, back, and lower extremity pain, and meningitis with lymphocytic pleocytosis (usually).
Assessment and Diagnostic Findings
To confirm the diagnosis, a sample of throat secretions, stool or a colorless fluid that surrounds your brain and spinal cord (cerebrospinal fluid) is checked for poliovirus.
Viral cultures. Obtain specimens from the cerebrospinal fluid (CSF), stool, and throat for viral cultures in patients with suspected poliomyelitis infection.
Serum antibody. Obtain acute and convalescent serum for antibody concentrations against the 3 polioviruses.
IG titer. A 4-fold increase in the immunoglobulin G (IgG) antibody titers or a positive anti-immunoglobulin M (IgM) titer during the acute stage is diagnostic.
Medical Management
The treatment of poliomyelitis is mainly supportive.
Physical therapy. Physical therapy is indicated in cases of paralytic disease; in paralytic disease, it provide frequent mobilization to avoid the development of chronic decubitus ulcerations; active and passive motion exercises are indicated during the convalescent stage.
Total hip arthroplasty. Total hip arthroplasty is a surgical therapeutic option for patients with paralytic sequelae of poliomyelitis who develop hip dysplasia and degenerative disease.
Diet. Because patients with poliomyelitis are prone to develop constipation, a diet rich in fiber is usually indicated.
Pharmacologic Management
No antiviral agents are effective against poliovirus.
Picornaviruses presentation for medical student created by: Farhang Shapouran
References : Moray medical microbiology, Jawetz medical microbiology, ICTV
Poliovirus is a picornaviridae. it has 3 wildtypes, Wildtype 2 has been eradicated from the world. All countries have been declared polio free except Pakistan, Afghanistan and Nigeria. Global Polio Eradication Initiative has been discussed.
Similar to epidemiological.study of polio .pptx (20)
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
2. CONTENTS
1- History Of Polio
2- Introduction
• What Is Polio?
• Different Types Of Polio
• Etiology
• Risk Factors
3- Mode Of Transmission
• Infectious Material
• How does it Transmit?
• Incubation Period Of Virus
4- Pathogenesis
5- Clinical Features
• Abortive Infection
• Paralytic Polio
• Non-paralytic Polio
6- Diagnosis
7- Treatment And Prevention
8- Epidemiology In Pakistan
9- Strategies
10- Conclusion
11- References
3. HISTORY
Poliomyelitis
• First described by Michael
• Underwood in 1789
• Developed countries in
• Northern Hemisphere
suffered increasingly severe
• epidemics in the first half
of the 20th century
• More than 21,000 paralytic
• cases reported in the U.S.
in 1952
• Last case of wild poliovirus
• acquired in the U.S. was 1979
• 1147 cases were reported in Pakistan in
in 1997
4. INTRODUCTION
What is polio?
• Poliomyelitis is an acute viral infection caused by an RNA virus.
• The term “Poliomyelitis” derives from the ancient Greek word
Polio’s means “grey” and myelos meaning “marrow” referring to
the grey matter of the spinal cord. The suffix itis denotes
inflammation, i.e. inflammation of the spinal cord’s grey matter.
5. DIFFERENT TYPES
1) Spinal Polio: It is the most common form
characterized by asymmetric paralysis that most often
involves the legs. 79% of paralytic cases
2) Bulbar Polio: This leads to weakness of muscles
innervated by cranial nerves. approximately 2% of
paralytic cases
3) Bulbospinal Polio: It is a combination of bulbar and
spinal paralysis approximately 19% of paralytic cases
It is primarily an infection of the human alimentary tract but the virus may infect the central
nervous system. (1%) of cases resulting in varying degrees of paralysis, and possible death
6. ETIOLOGY
• The causative agent is the poliovirus which has three
serotypes 1,2, and 3.
• Most outbreaks of paralytic polio are due to the type 1
virus.
• Poliovirus is a member of the enterovirus subgroup,
family Picornaviridae.
• Picornaviruses are small, ether-insensitive
viruses with an RNA genome.
• Poliovirus can survive for long periods in
the external environment.
• In a cold environment, it can live in water for
4 months and in feces for 6 months.
8. Risk Factors
Environmental Factors
Polio is likely to occur during the rainy season.
The environmental sources of infection are contaminated
water, food, and flies.
Poliovirus survives for a long time in a cold environment.
Overcrowding and poor sanitation provide opportunities
for exposure to infection.
Host Factors
Age: The disease occurs in all age groups, but children are
more susceptible.
• In Pakistan polio is essentially a disease of infancy and
childhood
• Gender: The ratio of male to female is 3:1
9. TRANSMISSION
Infectious Material • The virus is found in the feces and oropharyngeal secretions of an
infected person.
Mode Of Transmission
1. Fecal-oral Route
2. Droplet Infection
FECAL-ORAL ROUTE
• This is the main route of transmission in developing countries.
• The infection may spread directly through contaminated fingers where hygiene is poor, or
indirectly through contaminated water, milk, foods, flies, and articles of daily use.
DROPLET INFECTION
• This may occur during the acute phase of the disease when the virus occurs in the throat.
• Close personal contact with an infected person facilitates droplet spread.
• This mode of transmission may be relatively more important in developed countries.
10.
11. INCUBATION PERIOD OF VIRUS
7-14 days
Estimated to be about 2 weeks
The virus is excreted commonly for 2 to 3 weeks, sometimes as long as
3 to 4 months in feces.
In polio cases, infectivity in the pharyngeal foci is around one week,
and in the intestinal foci 6-8 weeks
PERIOD OF COMMUNICABILITY
RESERVOIR
Humans are the only known reservoir of poliovirus
CASE FATILITY
it varies from 1-10% according to form of disease (higher in
bulbar), complications and age
12. PATHOGENESIS
• The virus enters through the mouth and multiplies
in the oropharynx and gastrointestinal tract.
• The virus is usually present in nasopharyngeal
secretions for 1 to 2 weeks and can be shed in
stools for several weeks after infection, even in
individuals with minor symptoms or no illness.
• During intestinal replication, the virus invades local
lymphoid tissue and may enter the bloodstream, and
then infect cells of the central nervous system.
• Poliovirus-induced destruction of motor neurons of
the anterior horn of the spinal cord and brain stem
cells results in distinctive paralysis.
13.
14. CLINICAL SPECTRUM
Four basic patterns of Polio infections are as follows:-
• Subclinical infections
• Abortive infection
• Paralytic infection
• Non-paralytic infection
Inapparent (Subclinical) Infection
• This occurs approximately in 91 to 96% of poliovirus infections.
• There are no presenting symptoms and recognition is done only
by virus isolation.
Abortive Polio
• Is also called a minor illness.
• Occurs approximately 4 to 8 % of the infections.
• This is one of the earliest stages and most cases do not progress
further.
• At this stage the virus is beginning to infect cells and spread to
the lymphatic system.
• It includes symptoms like- General discomfort or
uneasiness(malaise), headache, red throat, slight fever, sore
throat, vomiting etc
15. NON PARALYTIC POLIO
• Occurs in approximately 1% of all infections.
• This stage is not common but occurs when the virus is not
destroyed by antibodies and spreads to the CNS.
• The presenting features are stiffness and pain in the neck and
back.
• The disease lasts for 2 to 10 days.
• The disease is synonymous with septic meningitis.
PARALYTIC POLIO
• It includes the development of flaccid paralysis (AFP) and affects
the central nervous system.
• Occurs in less than 1% of infections.
• The other associated symptoms are malaise, anorexia, nausea,
vomiting, constipation, and abdominal pain.
Cont.……..
16. • There might be signs of meningeal irritation, i.e., stiffness of neck and back muscles.
• The child finds difficulty in sitting and sits by supporting hands at the back and by
partially flexing the hips and knees.
• Paralysis is characterized as descending.
• e.g., starting at the hip and then moving down to the distal parts of the extremity.
• Progression of paralysis to reach its maximum in the majority of cases occurs in less than
4 days
• No sign of sensory loss.
Cont.…….
17. Complications and case fatality
Respiratory complications: pneumonia, pulmonary edema
Cardiovascular complications: myocarditis
Late complications: soft tissue and bone deformities,
osteoporosis, and chronic distension of the colon.
Case fatality: varies from 1% to 10% according to the form of
the disease (higher in bulbar), complications, and age ( fatality
increases with age).
18. DIAGNOSIS
The health care provider may find:-
• Abnormal reflexes, Back stiffness, Difficulty in movement
Tests include
• Cultures of throat washing, stools or spinal fluid, spinal tap, and
examination of the spinal fluid (CSF exam.) using PCR.
Virus isolation
The likelihood of poliovirus isolation is
• Highest from stool specimens,
• Intermediate from pharyngeal swabs
• Very low from blood or spinal fluid.
19. TREATMENT
The goal of the treatment is to control symptoms
as there is no specific treatment for this viral
infection.
Symptoms are treated based on their severity.
Treatment may include-
• Antibiotics for urinary tract infection
• Moist heat to reduce pain and spasms
• Pain killers to reduce headache, muscle pain,
and spasms
• Physical therapy or orthopedic surgery are also
provided to help in recovering muscle strength
and function
20. PREVENTION
Polio immunization(vaccine) effectively prevents poliomyelitis.
There are mainly two types of vaccines that are widely used to prevent
poliomyelitis.
1. Inactivated (Salk) Polio Vaccine (IPV)
Dr. Jonas Salk In 1953
• It is given as an injection in the leg or arm, depending on the patient’s age
at the angle of 45ºC
• Don’t inject it on the buttock because there are chances of abscess
formation.
• Prevents paralysis
• IPV is administered by subcutaneous injection with having 0.5ml syringe
and needle of number 24.
• The First dose is administered when the infant is 14 weeks old with OPV
3rd dose and 2nd is given when the infant is 9 months old.
• Induces humoral antibodies but not local immunity
• Protect the individual but do not prevent reinfection.
21. Oral (Sabin) Polio Vaccine (OPV)
4-types (mOPV, nOPV2, bOPV, tOPV)
Dr. Albert Sabin in 1957
• It contains a live attenuated virus (types 1,2, and 3, trivalent)
grown in primary monkey kidney or human diploid cell cultures.
• Shed in feces hence protect also surroundings.
• Zero doses to children delivered in hospitals.
• The first dose is administered when the infant is 6 weeks old.
The 2nd dose is when the infant is 10 weeks old and the third is
when the infant is 14 weeks old
• Vaccines type Bivalent OPV for serotype 1 and 3 and
Monovalent OPV for serotype 3 only are in use in Pakistan.
• It produces antibodies in the blood to all three types of
poliovirus.
• Prevents not only paralysis but also intestinal re-infection.
Cont…..
Case exception*: if the child is suffering from diarrhea, then the vaccine will not work
well, then give another dose after 4-weeks when the course is over.
23. Epidemiological distribution of polio in Pakistan
• Pakistan is one of three remaining polio-
endemic countries in the world, along with
Afghanistan and Nigeria
• Since the launch of Pakistan’s Polio
Eradication Programme in 1974 which
started work officially in 1994, there has
been a massive decline in polio cases in
Pakistan from approximately 20,000 every
year in the early 1990s to only few cases in
2022
27. Strategies to Control Polio In Pakistan
• Pakistan has made important progress toward
stopping poliovirus transmission in the country
.
• Since 1994, the Pakistan Polio Eradication
Program me has been fighting officially to
end the crippling poliovirus from the country.
28. • Throughout the year, the program implements high-quality vaccination
campaigns (containing almost 339,521 trained workers) that aim to
reach all children under the age of across Pakistan.
• The program is currently implementing the National Emergency
Action Plan (NEAP) for Polio Eradication.
• The program is committed to stopping all wild poliovirus type 1
(WPV1) and vaccine-derived poliovirus type 2 (VDPV2)
transmission in Pakistan.
Cont.…….
In 2008, The government of Pakistan
introduce the pentavalent vaccine which is a
combination of 5 vaccines (DPT-HepB-Hib)
In 2012 pneumococcal and in august 2015
IPV was introduced in Pakistan.
29. To achieve this goal, the program is focused on ensuring the
following objectives:
• Special attention to children who have the least access to
polio drops during the campaign.
• Acknowledging the basic importance of vaccines in the
polio program and highlighting its services in front of the
public.
• Taking steps on a war basis by adding the sensitive areas of
Polio to the priority-1.
• The establishment of the health camp, where EPI is also
informed with polio drops.
• Involvement and training of women volunteers in a
community-based vaccination program.
• Very good monitoring management.
Cont.….
32. CONCLUSION
1. Poliomyelitis is an acute enteroviral illness.
2. The most devastating result of poliovirus infection is ‘paralysis’.
3. This disease results in the destruction of motor neurons caused by
the polio virus
4. Vaccination is the only effective method of prevention.
World Polio Day
24 OCTOBER
33. REFRENCES
A Textbook of Microbiology by R. Ananthanarayan, C K Jayaram
Paniker, seventh edition, 2005, Page no: 491-494.
A Textbook of Microbiology by P. Chakraborty, 3rd edition, 2013, Page
No: 555-559.
https://www.unicef.org/pakistan/polioww
Pakistan Polio Update: http://endpolio.com.pk/media-room/pakistan-
polio-update